Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12605000266662
ACTRN12605000266662
Recruiting
Phase 4

Gestational Diabetes: pregnancy outcomes in treatment with metformin compared with insulin.

HRC0 sites750 target enrollmentSeptember 2, 2005
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGestational diabetesMetabolic and Endocrine - DiabetesReproductive Health and Childbirth - Fetal medicine and complications of pregnancy

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Gestational diabetes
Sponsor
HRC
Enrollment
750
Status
Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 2, 2005
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
HRC

Eligibility Criteria

Inclusion Criteria

  • •22\-33 weeks' gestation, singleton pregnancy, capillary glucose levels requiring additional treatment.

Exclusion Criteria

  • •Diabetes diagnosed pregnancy, gestational hypertension, pre\-eclampsia of fetal growth restriction at study entry, fetal congenital anomaly, maternal medical conditon posing contra\-indication to metformin.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Treatment outcomes for gestational diabetes diagnosed either according to WHO 2013 or WHO 1999 thresholds: the TANGO-DM Randomized Controlled Trial<p>GDM Diabetes gravidarum Gestational diabetes zwangerschapsdiabetes</p>10026908
NL-OMON23396eading the Change1,032
Completed
Not Applicable
Metformin for gestational diabetes mellitusGestational diabetes mellitus.
IRCT201306057841N4Isfahan University of Medical Sciences, Vice-Chancellery for Research100
Not yet recruiting
Not Applicable
A study to assess the Pregnancy outcome in women with Gestational Diabetes Mellitus diagnosed with only Abnormal fasting blood glucose compared to those with Normal fasting blood glucose on 75 grams Oral Glucose Tolerance Test.Health Condition 1: O244- Gestational diabetes mellitus
CTRI/2020/09/027940ot applicable
Not yet recruiting
Not Applicable
Study on prediction of risk for Diabetes during pregnancyHealth Condition 1: O244- Gestational diabetes mellitus
CTRI/2019/01/017119Osmania Medical College
Not yet recruiting
Phase 2
Pulverize Yam (D. Cayennensis) supplementation in the treatment of Gestational Diabetes MellitusGestational diabetesD27.505.696.422G07.203.300.572
RBR-26ymzkcniversidade Federal da Paraíba